Gene: FAM185A
Official Full Name: family with sequence similarity 185 member Aprovided by HGNC
Gene Summary: Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27125 | FAM185A Knockout cell line (HeLa) | Human | FAM185A | 1:3~1:6 | Negative | Online Inquiry |
KO27126 | FAM185A Knockout cell line (HCT 116) | Human | FAM185A | 1:2~1:4 | Negative | Online Inquiry |
KO27127 | FAM185A Knockout cell line (A549) | Human | FAM185A | 1:3~1:4 | Negative | Online Inquiry |
FAM185A Gene Knockout Cell Lines are genetically engineered cell models that have been specifically designed to silence the expression of the FAM185A gene. This gene is known to be involved in various cellular processes, and its knockout offers a unique opportunity for researchers to dissect its functional role in both normal physiology and disease states. The FAM185A knockout is achieved through CRISPR-Cas9 technology, allowing for precise genomic editing that facilitates the study of gene function at a level of accuracy that traditional methods cannot provide.
These cell lines exhibit key functions, including altered signaling pathways, which researchers can leverage to investigate cellular responses to different stimuli. By establishing a clearer understanding of the FAM185A gene's contributions, scientists can uncover potential links to various diseases, including cancer and metabolic disorders. This opens new avenues for targeted therapeutic strategies and enhances our understanding of disease mechanisms.
The scientific importance of FAM185A Gene Knockout Cell Lines cannot be overstated. They serve as valuable tools in both basic and applied research settings, enabling the exploration of gene function and the development of innovative treatments. Moreover, their application in drug discovery and toxicity testing positions them as essential assets for pharmaceutical companies seeking to understand the biological impacts of new compounds.
Compared to conventional gene manipulation techniques, FAM185A knockout cell lines provide several advantages, including enhanced reliability, specificity, and reproducibility of results. Traditional methods often result in off-target effects, which can complicate data interpretation. In contrast, the CRISPR-Cas9 approach minimizes these issues, offering a more accurate representation of gene function.
For researchers and clinicians focused on elucidating the roles of specific genes in disease, FAM185A Gene Knockout Cell Lines represent a crucial resource. They bring a powerful methodology that can facilitate breakthroughs in our understanding of gene interactions and their implications in health and disease.
Our company specializes in providing cutting-edge biological products tailored to meet the needs of the scientific community, ensuring that researchers are equipped with the tools necessary to advance their discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.